ANDREKA WINSTON: Open Payments
NPI 1700398005 · HAUGHTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 64 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $324 · 2025 $1,165
Food & beverage: $1,161Education: $4
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $261 |
| Axsome Therapeutics, Inc. | 11 | $190 |
| Alkermes, Inc. | 13 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $140 |
| Vanda Pharmaceuticals Inc. | 2 | $109 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Corium, LLC | 1 | $28 |
| Lundbeck LLC | 1 | $26 |
Products named: VRAYLAR, Auvelity, ARISTADA, CAPLYTA, REXULTI, FANAPT, Kerendia, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
